SCHEMBL4745982

SCHEMBL4745982

Cc1ccc2c(c1)c(-c1cc3c4cccc5c4c(cc3c3ccccc13)-c1ccccc1-5)cc1c3ccc(C)c4c3c(cc21)-c1ncccc1-4

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
HPGD P15428 2/20 0.34
MAPK1 P28482 2/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
HIF1A Q16665 1/20 0.34
HSD17B10 Q99714 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAPT P10636 3/20 0.33
KDM4E B2RXH2 3/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
PABPC1 P11940 1/20 0.33
HKDC1 Q2TB90 1/20 0.32
MEN1 O00255 2/20 0.31
HTT P42858 2/20 0.31
KMT2A Q03164 2/20 0.31
USP2 O75604 1/20 0.31
RECQL P46063 1/20 0.31
RAB9A P51151 1/20 0.31
TOP2A P11388 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4745981 0.97 ALDH1A1 (0.33) ALDH1A1HPGDMAPK1TSHRCASP1
SCHEMBL4746272 0.97 MAPT (0.32) MAPK1MAPTKDM4ESMN1; SMN2PABPC1
SCHEMBL4745880 0.96 MAPT (0.34) ALDH1A1HPGDMAPK1TSHRCASP1
SCHEMBL4745985 0.94 BCHE (0.33) ALDH1A1TOP2ABCHE
SCHEMBL4746394 0.93 MEN1 (0.32) ALDH1A1MAPK1MAPTKDM4ESMN1; SMN2
SCHEMBL4746409 0.92 PDK2 (0.33) ALDH1A1MAPK1L3MBTL1MAPTKDM4E
SCHEMBL4746466 0.91 TOP2A (0.32) ALDH1A1MAPK1MAPTKDM4ESMN1; SMN2
SCHEMBL4745860 0.90 MAOA (0.35) ALDH1A1HPGDHSD17B10MAPTKDM4E
SCHEMBL4746461 0.90 TOP2A (0.33) ALDH1A1MAPK1MAPTKDM4ESMN1; SMN2
SCHEMBL4745945 0.89 HPRT1 (0.37) ALDH1A1MAPK1L3MBTL1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-8173275-B2 Azaindenochrysene derivative and organic light-emitting device CANON KABUSHIKI KAISHA (JP) 2012-05-08 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE CANON KABUSHIKI KAISHA (JP) 2010-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100117526-A1 NOVEL AZAINDENOCHRYSENE DERIVATIVE AND ORGANIC LIGHT-EMITTING DEVICE NR2E3, OR51E2, AZI2 ALDH1A1 179/4885HPGD 1775/4885MAPK1 3618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.